EP0662782A4 - Pp14-based therapy. - Google Patents
Pp14-based therapy.Info
- Publication number
- EP0662782A4 EP0662782A4 EP93922763A EP93922763A EP0662782A4 EP 0662782 A4 EP0662782 A4 EP 0662782A4 EP 93922763 A EP93922763 A EP 93922763A EP 93922763 A EP93922763 A EP 93922763A EP 0662782 A4 EP0662782 A4 EP 0662782A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- based therapy
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95480292A | 1992-09-30 | 1992-09-30 | |
US954802 | 1992-09-30 | ||
PCT/US1993/009216 WO1994007366A1 (en) | 1992-09-30 | 1993-09-28 | Pp14-based therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0662782A1 EP0662782A1 (en) | 1995-07-19 |
EP0662782A4 true EP0662782A4 (en) | 1995-10-25 |
Family
ID=25495948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93922763A Withdrawn EP0662782A4 (en) | 1992-09-30 | 1993-09-28 | Pp14-based therapy. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0662782A4 (en) |
JP (1) | JPH08502257A (en) |
AU (1) | AU5165993A (en) |
CA (1) | CA2145762A1 (en) |
WO (1) | WO1994007366A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111743A0 (en) * | 1993-12-08 | 1995-01-24 | Intermune Life Sciences Inc | Recombinant genes expressing pp14 |
WO2001049163A1 (en) * | 2000-01-03 | 2001-07-12 | Tr Associates, L.L.C. | Pp14 fusion proteins and methods for making and using the same |
WO2004093907A2 (en) * | 2003-04-23 | 2004-11-04 | Tomoaki Hoshino | Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378418A2 (en) * | 1989-01-11 | 1990-07-18 | Intermune Life Sciences, Inc. | Immune cell proliferation inhibitors |
-
1993
- 1993-09-28 WO PCT/US1993/009216 patent/WO1994007366A1/en not_active Application Discontinuation
- 1993-09-28 JP JP6509255A patent/JPH08502257A/en active Pending
- 1993-09-28 CA CA002145762A patent/CA2145762A1/en not_active Abandoned
- 1993-09-28 AU AU51659/93A patent/AU5165993A/en not_active Abandoned
- 1993-09-28 EP EP93922763A patent/EP0662782A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378418A2 (en) * | 1989-01-11 | 1990-07-18 | Intermune Life Sciences, Inc. | Immune cell proliferation inhibitors |
Also Published As
Publication number | Publication date |
---|---|
EP0662782A1 (en) | 1995-07-19 |
AU5165993A (en) | 1994-04-26 |
CA2145762A1 (en) | 1994-04-14 |
WO1994007366A1 (en) | 1994-04-14 |
JPH08502257A (en) | 1996-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0597463A3 (en) | Thermotherapiesonde. | |
EP0580285A3 (en) | Auto-reclosers. | |
GR3025363T3 (en) | Medicaments. | |
GR3022484T3 (en) | Osteosynthesis aid. | |
EP0666752A4 (en) | Therapeutic microemulsions. | |
EP0572808A3 (en) | Antiblocage-system. | |
EP0668864A4 (en) | Substituted biphenylmethylimidazopyridines. | |
GB9203039D0 (en) | Treatment | |
EP0599191A3 (en) | Speed-governor-circuit. | |
EP0592354A3 (en) | Vacuum-centrifuge. | |
PH31659A (en) | Therapeutic nucleotides. | |
EP0663819A4 (en) | Ibuprofen-caffeine combinations. | |
ZA946217B (en) | Therapeutic combination | |
EP0662782A4 (en) | Pp14-based therapy. | |
EP0624089A4 (en) | Methods. | |
ZA935828B (en) | New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides. | |
ZA929916B (en) | Therapeutic agents. | |
ZA931403B (en) | Sulphonamidocarboxamides. | |
GB9323437D0 (en) | Therapy | |
EG19223A (en) | Therapeutic agents. | |
ZA933136B (en) | Therapeutic alcohols. | |
ZA928102B (en) | Therapeutic agent. | |
ZA939705B (en) | Inhalter devices. | |
GB9210270D0 (en) | Therapeutic combinations | |
GB9216088D0 (en) | Therapeutic combinations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950428 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19950912 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/10 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19980401 |